Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eui-Cheol Shin

Showing results (311-320 of 377) with videos related to

Pageof 38
Sort By:
Cellular & Molecular Immunology|April 26, 2020
PD-1 blockade-unresponsive human tumor-infiltrating CD8<sup>+</sup> T cells are marked by loss of CD28 expression and rescued by IL-15Kyung Hwan Kim, Hong Kwan Kim, Hyung-Don Kim, et al.
Yonsei Medical Journal|July 27, 2019
Cohort Profile: The Cardiovascular and Metabolic Diseases Etiology Research Center Cohort in KoreaJee Seon Shim, Bo Mi Song, Jung Hyun Lee, et al.
Thorax|July 21, 2017
Predictors of mortality in Middle East respiratory syndrome (MERS)Ki-Ho Hong, Jae-Phil Choi, Seon-Hui Hong, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2016
Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cellsJong Hoon Kim, Young Joon Choi, Byung Ha Lee, et al.
Scientific Reports|September 2, 2020
Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patientsSeung-Myoung Son, Chang Gok Woo, Dae Hoon Kim, et al.
The American Journal of Tropical Medicine and Hygiene|October 30, 2020
Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody ResponsesJi-Soo Kwon, Ji Yeun Kim, Min-Chul Kim, et al.
Science Immunology|January 19, 2024
Omicron BA.2 breakthrough infection elicits CD8<sup>+</sup> T cell responses recognizing the spike of later Omicron subvariantsSang-Hoon Kim, Jihye Kim, Sungmin Jung, et al.
Journal of Hepatology|August 19, 2020
Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinomaChang Gon Kim, Chan Kim, Sang Eun Yoon, et al.
Viruses|March 15, 2020
The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related VirusesEui-Cheol Shin, Ji Won Han, Wonseok Kang, et al.
Elife|July 5, 2021
Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2Dongjin Jeong, Hye Sung Kim, Hye Young Kim, et al.
Pageof 38

Showing results (311-320 of 377) with videos related to

Sort By:
Pageof 38
Cellular & Molecular Immunology|April 26, 2020
PD-1 blockade-unresponsive human tumor-infiltrating CD8<sup>+</sup> T cells are marked by loss of CD28 expression and rescued by IL-15Kyung Hwan Kim, Hong Kwan Kim, Hyung-Don Kim, et al.
Yonsei Medical Journal|July 27, 2019
Cohort Profile: The Cardiovascular and Metabolic Diseases Etiology Research Center Cohort in KoreaJee Seon Shim, Bo Mi Song, Jung Hyun Lee, et al.
Thorax|July 21, 2017
Predictors of mortality in Middle East respiratory syndrome (MERS)Ki-Ho Hong, Jae-Phil Choi, Seon-Hui Hong, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2016
Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cellsJong Hoon Kim, Young Joon Choi, Byung Ha Lee, et al.
Scientific Reports|September 2, 2020
Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patientsSeung-Myoung Son, Chang Gok Woo, Dae Hoon Kim, et al.
The American Journal of Tropical Medicine and Hygiene|October 30, 2020
Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody ResponsesJi-Soo Kwon, Ji Yeun Kim, Min-Chul Kim, et al.
Science Immunology|January 19, 2024
Omicron BA.2 breakthrough infection elicits CD8<sup>+</sup> T cell responses recognizing the spike of later Omicron subvariantsSang-Hoon Kim, Jihye Kim, Sungmin Jung, et al.
Journal of Hepatology|August 19, 2020
Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinomaChang Gon Kim, Chan Kim, Sang Eun Yoon, et al.
Viruses|March 15, 2020
The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related VirusesEui-Cheol Shin, Ji Won Han, Wonseok Kang, et al.
Elife|July 5, 2021
Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2Dongjin Jeong, Hye Sung Kim, Hye Young Kim, et al.
Pageof 38